Stay updated on Pembrolizumab for Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedA banner announces an NIH website transition and says agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page now shows a 403 Forbidden error, indicating access to the study record is blocked. The previous content and navigation for the record is replaced by an error page.SummaryDifference20%

- Check60 days agoChange DetectedRevision tag on the page updated from v3.6.5 to v3.6.6. This is a minor maintenance update that does not alter the study content or its key details.SummaryDifference0.1%

- Check81 days agoChange DetectedRepresents a software version update for the page, from v3.6.4 to v3.6.5. This deployment likely includes fixes or minor improvements and does not change the study content shown on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.